TTY Biopharm Company Limited (TPEX: 4105)

TTY Biopharm Company Revenue

TTY Biopharm Company had revenue of 1.53B TWD in the quarter ending September 30, 2024, with 7.02% growth. This brings the company's revenue in the last twelve months to 5.83B, up 8.03% year-over-year. In the year 2023, TTY Biopharm Company had annual revenue of 5.51B with 8.77% growth.

• Revenue (ttm): 5.83B
• Revenue Growth: +8.03%
• P/S Ratio: 3.13
• Revenue / Employee: 17.04M
• Employees: 342
• Market Cap: 18.25B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	5.51B	443.94M	8.77%
Dec 31, 2022	5.06B	526.00M	11.60%
Dec 31, 2021	4.54B	313.77M	7.43%
Dec 31, 2020	4.22B	-244.47M	-5.47%
Dec 31, 2019	4.47B	430.11M	10.66%